Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
British Journal of Sports Medicine|December 18, 2014
Diagnostic accuracy of clinical tests for the diagnosis of hip femoroacetabular impingement/labral tear: a systematic review with meta-analysisM P Reiman, A P Goode, C E Cook, et al.
Current Biology : CB|May 30, 2001
Hox genes and the phylogeny of the arthropodsC E Cook, M L Smith, M J Telford, et al.
Clinical Pharmacology and Therapeutics|March 1, 1984
Effect of influenza vaccine on warfarin anticoagulationP Kramer, M Tsuru, C E Cook, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 1995
Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sitesY Pommier, G Kohlhagen, K W Kohn, et al.
Journal of Computer-Aided Molecular Design|January 1, 1997
Comparative molecular field analysis and molecular modeling studies of 20-(S)-camptothecin analogs as inhibitors of DNA topoisomerase I and anticancer/antitumor agentsS W Carrigan, P C Fox, M E Wall, et al.
Journal of Natural Products|July 1, 1983
Plant antitumor agents, 19. Novel triterpenes from Maprounea africanaM C Wani, J P Schaumberg, H L Taylor, et al.
Human Reproduction (Oxford, England)|June 1, 1994
Effects of D-ring substituents on antiprogestational (antagonist) and progestational (agonist) activity of 11 beta-aryl steroidsC E Cook, Y W Lee, M C Wani, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 31, 1998
Molecular instability in the COII-tRNA(Lys) intergenic region of the human mitochondrial genome: multiple origins of the 9-bp deletion and heteroplasmy for expanded repeatsM G Thomas, C E Cook, K W Miller, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1987
Pharmacokinetics of pentobarbital enantiomers as determined by enantioselective radioimmunoassay after administration of racemate to humans and rabbitsC E Cook, T B Seltzman, C R Tallent, et al.
Life Sciences|January 1, 1993
Reversal of activity profile in analogs of the antiprogestin RU 486: effect of a 16 alpha-substituent on progestational (agonist) activityC E Cook, M C Wani, Y W Lee, et al.
Pageof 18